Cargando…

Efficacy and Safety of Rituximab Therapy for Lupus Nephritis Among SLE Female Patients; a Retrospective Hospital-Based Study

BACKGROUND: Renal affection in systemic lupus erythematosus (SLE) is a high-risk manifestation in which novel treatment strategies are required, particularly in patients who show lower response to conventional therapy. Rituximab has been used as an off-label treatment for lupus nephritis (LN) for th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdelkarim Aloub, Khansa Osama, Eltahirm, Noha Ibrahim Ahmed, Elagib, Elnour Mohammed, Adam Essa, Mohammed Elmujtba, Hussein, Mustafa Mohammed Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758987/ https://www.ncbi.nlm.nih.gov/pubmed/36536922 http://dx.doi.org/10.2147/OARRR.S391091

Ejemplares similares

Vesiculobullous disease with Cutaneous Systemic Lupus Erythematosus Treated by Rituximab: A case report
por: Mohammed Niamat Alla, Wigdan, et al.
Publicado: (2021)

Analysis of Serum Immune Markers in Seropositive and Seronegative Rheumatoid Arthritis Among Sudanese Patients and the Relation Between the Serotype and Joint Involvement: A Cohort Study
por: Seri, Ahmed, et al.
Publicado: (2021)

Recurrent Stevens–Johnson syndrome in a patient with systemic lupus erythematosus: a case report
por: Ahmed Eltahir, Noha Ibrahim, et al.
Publicado: (2020)

A Rare Association of Thrombotic Thrombocytopenic Purpura with Systemic Lupus Erythematosus in a Sudanese Woman: Case Report
por: Ibn Idris Rodwan, Amel Awad, et al.
Publicado: (2021)

SLE - Rituximab in lupus
por: Eisenberg, Robert
Publicado: (2003)

Incidence and Clinical Pattern of Mixed Connective Tissue Disease in Sudanese Patients at Omdurman Military Hospital: Hospital-Based Study
por: Abdelgalil Ali Ahmed, Sulafah, et al.
Publicado: (2021)

Systemic lupus erythematous as an unusual cause of intussusception in Sudanese woman: A case report
por: Salih Mohammadeen, Salwa Dafa Allah, et al.
Publicado: (2021)

Neutrophilic dermatoses in a seronegative rheumatoid arthritis patient: A case report
por: IbnIdris Rodwan, Amel Awad, et al.
Publicado: (2022)

Involvement of Gut Microbiota in SLE and Lupus Nephritis
por: Mohd, Rozita, et al.
Publicado: (2023)

Clinical efficacy and safety of rituximab in lupus nephritis
por: Zhong, Zhiqing, et al.
Publicado: (2019)

Rituximab for treatment of severe lupus nephritis
por: Baskin, E, et al.
Publicado: (2008)

SLE Plasma Profiling Identifies Unique Signatures of Lupus Nephritis and Discoid Lupus
por: Smith, Michael A., et al.
Publicado: (2019)

Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE
por: Gilbert, Mileka, et al.
Publicado: (2021)

Effective use of rituximab in combination with low dose cyclophosphamide in childhood onset systemic lupus erythematosus (SLE) with relapsing class IV nephritis
por: Miettunen, PM, et al.
Publicado: (2008)

Rituximab Used for the Treatment of Nonuremic Calciphylaxis: A Complication of Prolonged Steroid Use in Lupus Nephritis
por: Kahn, Cameron, et al.
Publicado: (2022)

Rituximab can Decrease Proteinuria in Refractory Lupus Nephritis
por: Suh, Chang-Hee
Publicado: (2022)

Susceptibility of BAFF-var allele carriers to severe SLE with occurrence of lupus nephritis
por: Friebus-Kardash, Justa, et al.
Publicado: (2019)

Coincidental light chain induced proximal tubulopathy with lupus nephritis: a case report and review of the literature
por: Hamza, Wael Mostafa, et al.
Publicado: (2021)

Dramatic Response of Lupus Enteritis, Nephritis, and Pancytopenia to Plasmapheresis and Rituximab
por: Aftab, Adan, et al.
Publicado: (2022)

Accumulation of antinuclear associated antibodies in circulating immune complexes is more prominent in SLE patients from Sudan than Sweden
por: Elbagir, Sahwa, et al.
Publicado: (2020)

Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy
por: Tanaka, Yoshiya, et al.
Publicado: (2016)

In ovo injection corticosterone method for physiological and behavioral studies in chickens
por: Ahmed, Abdelkareem A., et al.
Publicado: (2020)

Neuropsychiatric Lupus and Lupus Nephritis Successfully Treated with Combined IVIG and Rituximab: An Alternative to Standard of Care
por: Cheikh, Mohamed M., et al.
Publicado: (2022)

Autoantibodies against Modified Histone Peptides in SLE Patients Are Associated with Disease Activity and Lupus Nephritis
por: Dieker, Jürgen, et al.
Publicado: (2016)

MiRNA Regulation of MIF in SLE and Attenuation of Murine Lupus Nephritis With miR-654
por: Tu, Yang, et al.
Publicado: (2019)

Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLE
por: Elbagir, Sahwa, et al.
Publicado: (2021)

Rituximab is effective in the treatment of nephritis in lupus patients, refractory to conventional immunosuppressive therapy
por: Martínez, R, et al.
Publicado: (2010)

Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-γ monoclonal antibody, in SLE subjects without or with lupus nephritis
por: Boedigheimer, Michael J, et al.
Publicado: (2017)

SLE presenting as migratory arthritis, chorea and nephritis
por: Ajmani, Sajal, et al.
Publicado: (2018)

Use of Rituximab in child with SLE and myocardial involvement
por: Balan, S, et al.
Publicado: (2008)

SLE‐associated myelitis successfully treated by rituximab
por: Khabbazi, Alireza, et al.
Publicado: (2022)

Comparison between D‐dimer levels in diabetic and non‐diabetic positive COVID‐19 adult patients: A hospital‐based study
por: Hashim Ibrahim Elbashir, Ibrahim, et al.
Publicado: (2022)

Acquired Protein S Deficiency in a Patient with Lupus Nephritis
por: Meriam, Hajji, et al.
Publicado: (2019)

Early-Onset Neutropenia Induced by Rituximab in a Patient with Lupus Nephritis and Hemolytic Anemia
por: Arroyo-Ávila, Mariangelí, et al.
Publicado: (2015)

Rituximab alone as induction therapy for membranous lupus nephritis: A multicenter retrospective study
por: Chavarot, Nathalie, et al.
Publicado: (2017)

Generation of evidence supporting the content validity of SF-36, FACIT-F, and LupusQoL, and novel patient-reported symptom items for use in patients with systemic lupus erythematosus (SLE) and SLE with lupus nephritis (LN)
por: Williams-Hall, Rebecca, et al.
Publicado: (2022)

Lupus nephritis is associated with poor pregnancy outcomes in pregnant SLE patients in Cape Town: a retrospective analysis
por: Mbuli, Lindisa, et al.
Publicado: (2015)

SLE stratification based on BAFF and IFN-I bioactivity for biologics and implications of BAFF produced by glomeruli in lupus nephritis
por: Itotagawa, Eri, et al.
Publicado: (2022)

Predictive and prognostic factors influencing outcomes of rituximab therapy in systemic lupus erythematosus (SLE): A systematic review()
por: Pirone, Carmelo, et al.
Publicado: (2017)

Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis
por: Atisha‐Fregoso, Yemil, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b6b17mobevnm5itiv8kg8tvvcv